CAR‑T Cell Therapy in Hyderabad
Updated August 2026 · Dr. Madhav Danthala
Can the body fight cancer on its own? If not, can we train it to do so? One of the most advanced answers is CAR-T cell therapy in Hyderabad — a treatment where a patient's own immune cells are engineered to recognize and destroy cancer. CAR-T is primarily used for blood cancers, often after consultation with a hematologist / hemato-oncologist or when bone marrow transplant isn't suitable.
This page explains what CAR-T cells are, how they are made, who needs this treatment, what risks exist, what happens after infusion, and why the therapy is expensive. Click a topic below to expand. Need expert guidance? Get a second opinion to determine if CAR-T therapy is right for you.
Consults in Begumpet & Manikonda
Looking for CAR-T cell therapy near me in Hyderabad? CAR-T eligibility is decided in consultation, not over the phone — here is where that consultation happens.
KIMS-Sunshine Hospitals, Begumpet
Room 545, 5th Floor OPD — Metro Pillar C1327, beside Jamia Masjid, Prakash Nagar, Begumpet, Hyderabad 500003. Mon–Sat, 9 AM–5 PM, booked online (no phone booking needed). Nearest Metro: Begumpet, Blue Line. Straightforward from Secunderabad, Ameerpet, Panjagutta, Sanath Nagar, Bowenpally and Kompally. Eligibility assessment, disease re-staging, prior-therapy review and organ-function testing before CAR-T are done here, alongside the transplant unit that provides the alternative path when CAR-T is not the right answer.
Peoples Polyclinic, Manikonda
1st Floor, Sree Srinivasam Building, B24 & B25, Panchavati & Sailakshmi Colony, Manikonda, Hyderabad 500089. Mon–Sat, 6 PM – 8 PM, prior appointment only — call Naresh on +91 80089 83828. The evening option for west Hyderabad: Gachibowli, Kondapur, Madhapur, Narsingi, Nanakramguda, Puppalaguda and the Financial District. Suited to the first conversation about CAR-T — whether it applies to your diagnosis, what it would cost, and what the realistic alternatives are — before committing to a workup.
Coming from outside Hyderabad — Warangal, Karimnagar, Nizamabad, Vijayawada or Visakhapatnam? Send your reports ahead for a written second opinion or request a callback before you book travel, so the first visit is a decision rather than a data-collection trip.
Watch: CAR-T Cell Therapy Explained
A clear visual explanation of how CAR-T therapy works, who needs it, and what to expect.
Explore by Topic
CAR-T explained (foundations)
Can the immune system fight cancer?
Can the immune system fight cancer?
Our immune system detects and destroys viruses, bacteria, and foreign invaders because they look "non-self." Cancer is different: cancer cells come from our own body, often look normal, and hide from immune detection. Simply "boosting immunity" through diet, supplements, or lifestyle cannot cure cancer. The immune system needs help recognizing cancer — that's where CAR-T therapy comes in.
What are T cells?
What are T cells?
T-cells are the immune system's security guards. They move through the body constantly checking cells. When they find infected or abnormal cells, they activate and destroy them. But cancer cells can disguise themselves and escape detection. CAR-T therapy reprograms T-cells to identify cancer more clearly.
What is CAR-T cell therapy?
What is CAR-T cell therapy?
CAR-T stands for Chimeric Antigen Receptor T-Cell Therapy. T-cells are taken from the patient's blood, genetically modified in a lab, trained to recognize cancer, and returned to the patient. Once infused, these cells find cancer cells, attach to them, and kill them. They can continue multiplying inside the body — often called a "living drug."
How are CAR-T cells made?
How are CAR-T cells made?
Step 1 — T-cell collection: blood is drawn and T-cells are separated (leukapheresis). Step 2 — Genetic modification: a special gene is added so they recognize a specific protein on cancer cells (transduction). Step 3 — Expansion: modified cells are grown in large numbers. Step 4 — Lymphodepleting chemotherapy: short chemo before infusion to make space for CAR-T cells. Step 5 — Infusion: CAR-T cells are infused back; inside the body they begin targeting cancer cells.
Who it's for & pathway
Who needs CAR-T therapy?
Who needs CAR-T therapy?
Usually considered for: relapsed leukemia, refractory lymphomas, disease returning after transplant, cancers not responding to standard treatments. It is not a first-line therapy in most cases. Patient selection depends on cancer type, disease burden, overall health, and prior treatments.
How long does it take?
How long does it take?
Manufacturing time varies: around 3 weeks in India, up to 6 weeks internationally. During this period, doctors may use bridging therapy to keep the disease under control.
Risks, side effects, limitations
Risks and side effects
Risks and side effects
CAR-T therapy can cause strong immune reactions. Cytokine Release Syndrome (CRS): symptoms may include fever, low blood pressure, breathing difficulty; severe cases can affect organs. Neurological effects: possible confusion, slurred speech, tremors, seizures. Most cases are treatable with steroids and tocilizumab.
After CAR-T (monitoring, response, follow-up)
What happens after CAR-T?
What happens after CAR-T?
CAR-T cells may destroy both cancerous and normal B-cells, leading to hypogammaglobulinemia (reduced antibodies, higher infection risk). Management may include preventive antibiotics and IVIG infusions.
How do we know CAR-T is still working?
How do we know CAR-T is still working?
If B-cells remain absent, it suggests CAR-T cells are still active. Doctors may monitor using PCR testing and blood markers. Relapses usually occur within the first year if they happen.
Different types of CAR-T therapies
Different types of CAR-T therapies
Not all CAR-T treatments are the same. They differ in target proteins (CD19, BCMA, etc.), genetic design, and cell source. Each therapy is like a key designed to fit a specific lock. If the cancer does not express that target, the therapy may not work.
Cost and access
Cost of CAR-T therapy
Cost of CAR-T therapy
CAR-T therapy is highly personalized. Estimated cost: around ₹50 lakhs in India. Why it's expensive: custom manufacturing for each patient, genetic engineering process, specialized labs, hospital monitoring. This remains one of the biggest barriers to access.
Limitations
Limitations
CAR-T is not a cure for every cancer. Challenges include: some patients relapse, manufacturing failures, T-cell quality variation, high cost. However, response rates in relapsed leukemia and lymphoma have been very encouraging.
Future & innovation
The future
The future
Research is ongoing in solid tumors, universal donor CAR-T cells, safer constructs, and faster manufacturing. CAR-T therapy represents a major shift toward immune-based cancer treatment — but it is still evolving.
Frequently Asked Questions
What is CAR-T cell therapy?
CAR-T therapy is a treatment where a patient's own immune cells (T-cells) are engineered to recognise and destroy cancer. The cells are collected, modified in a lab to express a chimeric antigen receptor, multiplied, then infused back into the patient — where they continue to act as a "living drug."
Who needs CAR-T therapy?
CAR-T is used mainly for certain blood cancers — relapsed or refractory B-cell leukemia, lymphoma, and myeloma — that have not responded to standard treatment. It is not a first-line therapy in most cases, and may be considered when a bone marrow transplant is not suitable. Watch Dr. Danthala on MedPlus ONE TV.
What are the uses and indications for CAR-T cell therapy?
Common indications centre on relapsed or refractory B-cell acute lymphoblastic leukemia, certain B-cell lymphomas, and relapsed or refractory multiple myeloma after prior lines of therapy. Eligibility depends on disease type, prior treatments, organ function, and centre capability. Benefits can include deep remissions when standard options are exhausted. Watch the full Short on MedPlus ONE TV.
How long does CAR-T therapy take?
From T-cell collection to infusion, the process typically takes about 3–4 weeks (longer if cells are manufactured abroad). During manufacturing, bridging therapy may be used to keep the disease controlled. The hospital stay around infusion and monitoring varies by patient and product.
What are the risks of CAR-T therapy?
The two main risks are cytokine release syndrome (CRS) and neurotoxicity. Both are monitored closely in specialised centres and are usually manageable with supportive care, steroids, and tocilizumab. Longer term, reduced antibody levels can raise infection risk and may need preventive treatment.
How much does CAR-T therapy cost in India?
CAR-T is expensive because each dose is manufactured individually for the patient. Indian-made CAR-T products have brought costs down substantially compared with imported therapies, though it remains a major investment. Costs vary by product and centre, and some assistance programmes may help with access. A consultation can clarify whether CAR-T is appropriate before cost is discussed in detail.
Is CAR-T cell therapy available in Hyderabad?
CAR-T cell therapy access in India is expanding through specialised centres. Dr. Madhav Danthala, a hematologist and hemato-oncologist in Hyderabad, evaluates eligibility for CAR-T in relapsed or refractory leukemia, lymphoma and multiple myeloma, and counsels patients on indications, risks and alternatives — including bone marrow transplant. Consult at KIMS-Sunshine Hospitals, Begumpet, or at the evening clinic in Manikonda — see where to consult.